GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Osteopore Ltd (ASX:OSX) » Definitions » Common Stock

Osteopore (ASX:OSX) Common Stock : A$29.53 Mil (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Osteopore Common Stock?

Osteopore's quarterly common stock increased from Dec. 2022 (A$26.96 Mil) to Jun. 2023 (A$29.47 Mil) and increased from Jun. 2023 (A$29.47 Mil) to Dec. 2023 (A$29.53 Mil).

Osteopore's annual common stock increased from Dec. 2021 (A$26.07 Mil) to Dec. 2022 (A$26.96 Mil) and increased from Dec. 2022 (A$26.96 Mil) to Dec. 2023 (A$29.53 Mil).


Osteopore Common Stock Historical Data

The historical data trend for Osteopore's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Osteopore Common Stock Chart

Osteopore Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Common Stock
Get a 7-Day Free Trial 19.19 26.07 26.07 26.96 29.53

Osteopore Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Common Stock Get a 7-Day Free Trial Premium Member Only 26.07 26.07 26.96 29.47 29.53

Osteopore Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Osteopore (ASX:OSX) Business Description

Traded in Other Exchanges
N/A
Address
Ground Floor, 16 Ord Street, West Perth, Perth, WA, AUS, 6005
Osteopore Ltd is engaged in the production of 3D printed bioresorbable implants that are used in conjunction with surgical procedures to assist bone healing. Its products include Osteoplug, which is a bioresorbable implant used for covering trephination burr holes in neurosurgery and Osteomesh which is a bioresorbable implant used in craniofacial surgery. Business operating segments are based on the firm's geographical presence in Singapore and Australia.

Osteopore (ASX:OSX) Headlines

No Headlines